Abstract:Backgrouds: Beta-secretase 1 (BACE1) is the rate-limiting enzyme in amyloidogenesis. We have recently reported that plasma BACE1 activity may predict Alzheimer’s disease as surrogate biomarkers, and BACE1 protein and activity levels are increased in cortical vessels from patients with cerebral amyloid angiopathy (CAA). However, little is known about the plasma BACE1 levels in CAA. Methods: A single-center prospective cohort of probable CAA patients admitted to Huashan Hospital from December 2014 to September 2017 were age, sex and education matched with elder adults from population-based Shanghai Aging Study cohort. We collected the clinical data, plasma and imaging markers. We measured plasma BACE1 concentration with our in house ELISA and BACE1 activity as we recently described. BACE1 concentration and activity were compared between CAA and controls and within CAA patients according to disease severity using generalized linear models. Results: There were 40 CAA patients with mean age of 73.3 years and 41 controls of 72.8 years. Compared with heathy controls, CAA patients showed a higher BACE1 protein concentration (5.44 [3.39, 9.17] ng/ml vs. 7.37 [5.38, 11.88] ng/ml, p=0.009), higher BACE1 activity (218.8±96.0 mFU/min vs. 285.7±119.4 mFU/min, p=0.007) and higher BACE1 activity per total plasma protein (6.99.0±3.07 mFU/min vs. 9.01±4.27 mFU/min, p=0.017), with no significant differences in BACE1 activity-to-concentration ratio (32.46 [20.11, 70.46] vs. 34.27 [17.23, 54.12], p=0.484). A cutoff value of BACE1 activity 252.6 mFU/min was determined to differentiate CAA from healthy elders with a sensitivity of 0.575 and a specificity of 0.683. For CAA patients, plasma BACE1 activity was higher in the severe group (total SVD score ≥4, n=10, 371.62±110.09 mFU/min) than in the mild group (total SVD score <4, n=30, 257.04±109.61 mFU/min, p=0.012). No significant differences were found in CMBs>10 vs. CMBs≤10 group (p=0.600). Conclusions: Plasma BACE1 concentration and activity are increased in CAA patients. Our results indicate that plasma BACE1 may be a promising biomarker for CAA diagnosis and have potential values in disease severity grading. A larger CAA cohort has been recruited to further validate the results.

β-myloid precursor protein cleavage enzyme-1 extracted from formalin-fixed,paraffin-embedded tissue following different sodium dodecyl sulfate concentration treatment

Expression, Purification and Activity Measurement of Soluble BACE Protein in E.coli.

Comparison of Different Buffers for Protein Extraction from Formalin-Fixed and Paraffin-Embedded Tissue Specimens

Tissue Microarrays in Pathological Examination of Apoptotic Acinar Cells Induced by Dexamethasone in the Pancreas of Rats with Severe Acute Pancreatitis

[Influence of Ultrasonic Processing on the Aggregation of PrP-Sc in the Brain Extracts of the Scrapie-Infected Hamsters].

An Enzyme-Linked Immunosorbent Assay To Compare The Affinity Of Chemical Compounds For Beta-Amyloid Peptide As A Monomer

Disease-Specific α-Synuclein Seeding in Lewy Body Disease and Multiple System Atrophy Are Preserved in Formaldehyde-Fixed Paraffin-Embedded Human Brain

Small interference RNA inhibits the endogenous expression of beta-site APP cleaving enzyme-1 protein in neuro-2a cells

A Simple and Label-Free Electrochemical Method for Detection of Beta-Site Amyloid Precursor Protein Cleaving Enzyme and Screening of Its Inhibitor

Design, Synthesis And Evaluation Of 3-(2-Aminoheterocycle)-4-Benzyloxyphenylbenzamide Derivatives As Bace-1 Inhibitors

O4‐02‐01: A Novel Role of Beta‐secretase1 (BACE1) in the Pathogenesis of Cerebral Amyloid Angiopathy (CAA)

An enzyme-linked immunosorbent assay to compare the affinity of chemical compounds for β-amyloid peptide as a monomer

Effects of Disulfide Bonds on Bindings of Inhibitors to BACE1 Decoded by Multiple Replica Accelerated Molecular Dynamics Simulations.

Optimal Percoll concentration facilitates flow cytometric analysis for annexin V/propidium iodine-stained ischemic brain tissues.

BACE1 RNA interference improves spatial memory and attenuates Aβ burden in a streptozotocin-induced tau hyperphosphorylated rat model.

Abstract WP555: Plasma Beta-Secretase 1 in Cerebral Amyloid Angiopathy

Ex vivo investigation of betaine and boric acid function as preprotective agents on rat synaptosomes to be treated with Aβ (1–42)

Evaluation of Decalcification Techniques for Rat Femurs Using HE and Immunohistochemical Staining

Binding of Inhibitors to BACE1 Affected by pH-Dependent Protonation: An Exploration from Multiple Replica Gaussian Accelerated Molecular Dynamics and MM-GBSA Calculations

Lys203 and Lys382 Are Essential for the Proteasomal Degradation of BACE1

A Novel Role Of Beta-Secretase 1 (Bace1) In The Pathogenesis Of Cerebral Amyloid Angiopathy (Caa)